Advisors and Consultants

Ananth Annapragada - Scientific Advisor
Ananth Annapragada is Professor of Radiology and Director of Basic Research in the Edward B. Singleton Department of Pediatric Radiology at Texas Childrens Hospital. Previously, he was the Robert Graham Professor of Entrepreneurial Biomedical Informatics and Bioengineering at the School of Biomedical Informatics at the University of Texas, Health Sciences Center at Houston. He holds additional positions at the Graduate School of Biomedical Sciences, the Keck Institute for Computational and Structural Biology, The University of Houston, Rice University and the University of Texas at Austin. Prior to UT, he was at the Cleveland Clinic/Cleveland State University Program in Biomedical Engineering, as Associate Professor and Program Director.

Ananth received his Ph.D. in Chemical Engineering from The University of Michigan in 1989. After Post-Doctoral Fellowships at the University of Minnesota and MIT, he joined Abbott Laboratories as a Research Scientist in 1991. In 1996, he joined SEQUUS Pharmaceuticals, Menlo Park, CA. He stayed with SEQUUS through its merger with ALZA, and when ALZA was acquired by Johnson and Johnson, he left for his first Academic position in 2000, at the Cleveland State University and Cleveland Clinic Foundation. In 2003, he moved to UT. He moved to TCH in June 2011.

Ketan Ghaghada - Scientific Advisor
Ketan is an Assistant Professor and Manager of Basic Science Research Program in the Edward B. Singleton Department of Pediatric Radiology at Texas Children's Hospital. He also holds a faculty appointment in the Department of Radiology at Baylor College of Medicine. Previously, Ketan served on the faculty of the University of Texas Health Science Center at Houston.

Ketan received his Ph.D. in Chemical Engineering from The University of Houston in 2006. He went on to do a post-doctoral fellowship in the Department of Radiology and the Center for In Vivo Microscopy at Duke University Medical Center and later at the University of Texas at Houston. Ketan has worked extensively on the development and pre-clinical testing and process/product development of nanoparticles for use as contrast agents in computed tomography (CT) and magnetic resonance imaging (MRI).